Arnold & Porter Expands EU Life Sciences Team with Partner Fabien Roy in Brussels
BRUSSELS, January 13, 2026 — Arnold & Porter announced today that Fabien Roy has joined the firm’s Life Sciences & Healthcare Regulatory practice as a partner, resident in Brussels.
Niels Christian Ersbøll, head of Arnold & Porter’s Brussels office, said: “Fabien brings deep sector experience and technical acumen that enables him to help clients navigate complex EU regulatory frameworks. His reputation in Brussels for medical device and pharma regulatory matters, combined with his knowledge of artificial intelligence (AI) and data privacy issues, makes him an exceptional addition to our team.”
Dan Kracov, chair of the firm’s Global Life Sciences Industry group, added: “Fabien’s arrival reinforces our ability to provide comprehensive regulatory counsel to life sciences companies wherever they do business. His knowledge of medical devices and emerging technologies, including AI-driven health solutions, will be invaluable as clients face increasingly complex compliance challenges around the globe.”
Fabien advises life science technology companies on EU and international regulatory matters, with a focus on medical devices, diagnostics, and pharmaceuticals. He regularly counsels clients on AI-driven health technologies and Conformité Européenne marking of medical devices. Fabien also assists in addressing complex issues that arise during clinical studies, conformity assessment audits or inspections, and post-market activities. He is a qualified lead auditor for ISO 13485 quality management systems and regularly prepares, drafts, and reviews agreements related to clinical studies, registries, distribution, sponsor’s representatives, CROs, and European Authorized Representative Agreements. Fabien adds to the firm’s globally recognized medical device and technology practice, joining a team of 65 lawyers, including 22 partners, focused on life sciences regulatory matters across the U.S., UK, Belgium, the Netherlands, and China.
In joining the firm, Fabien said: “I am excited to join Arnold & Porter as a partner in Brussels and to contribute to the firm’s growing life sciences and regulatory practice. With the evolving EU regulatory landscape—particularly in medical devices, pharma, digital health, and AI, clients need strategic, technically robust, and business-oriented advice. Arnold & Porter offers an outstanding platform to deliver that support at both the EU and international levels.”
Fabien holds a Master Degree on European Laws, with merit, from Université de Rennes 1 and a Master of Public Law from the University of Silesia (Poland).
About Arnold & Porter
Arnold & Porter combines sophisticated regulatory, litigation, and transactional capabilities to resolve clients’ most complex issues. With over 1,000 lawyers practicing in 16 offices worldwide, we offer an integrated approach that spans more than 40 practice areas. Through multidisciplinary collaboration and focused industry experience, we provide innovative and effective solutions to mitigate risks, address challenges, and achieve successful outcomes.
